(0.64%) 5 160.71 points
(0.33%) 38 803 points
(0.71%) 16 271 points
(0.90%) $78.81
(3.83%) $2.22
(1.10%) $2 334.10
(3.03%) $27.50
(0.63%) $971.40
(-0.15%) $0.927
(-0.55%) $10.81
(-0.29%) $0.795
(-0.06%) $91.40
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 16.70%
1.85% $ 1.925
@ $2.97
Wydano: 14 vas. 2024 @ 16:30
Zwrot: -35.17%
Poprzedni sygnał: vas. 13 - 19:28
Poprzedni sygnał:
Zwrot: 2.92 %
Live Chart Being Loaded With Signals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology...
Stats | |
---|---|
Dzisiejszy wolumen | 475 805 |
Średni wolumen | 1.89M |
Kapitalizacja rynkowa | 285.39M |
EPS | $0 ( 2024-03-06 ) |
Następna data zysków | ( $-0.120 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.28 |
ATR14 | $0.00800 (0.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Sherman Jeffrey W | Buy | 6 502 | Common Stock |
2024-03-15 | Kong Garheng | Buy | 6 474 | Common Stock |
2024-03-15 | Johnson John | Buy | 89 571 | Common Stock |
2024-03-18 | Johnson John | Buy | 215 600 | Common Stock |
2024-03-18 | Johnson John | Sell | 215 600 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
92.67 |
Last 99 transactions |
Buy: 12 203 668 | Sell: 238 056 |
Wolumen Korelacja
Xeris Pharmaceuticals Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
IRWD | 0.917 |
WRAP | 0.87 |
ZS | 0.866 |
GTEC | 0.857 |
TELA | 0.854 |
NEPH | 0.852 |
DLHC | 0.852 |
ASUR | 0.842 |
MFH | 0.841 |
PGNY | 0.84 |
10 Najbardziej negatywne korelacje | |
---|---|
TLMD | -0.886 |
EPZM | -0.862 |
RING | -0.832 |
SLVO | -0.829 |
XOG | -0.828 |
CNCE | -0.827 |
RMRM | -0.819 |
SIVBP | -0.817 |
MGEE | -0.812 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Xeris Pharmaceuticals Inc Korelacja - Waluta/Towar
Xeris Pharmaceuticals Inc Finanse
Annual | 2024 |
Przychody: | $163.91M |
Zysk brutto: | $124.43M (75.91 %) |
EPS: | $-0.450 |
FY | 2024 |
Przychody: | $163.91M |
Zysk brutto: | $124.43M (75.91 %) |
EPS: | $-0.450 |
FY | 2023 |
Przychody: | $110.25M |
Zysk brutto: | $87.61M (79.47 %) |
EPS: | $-0.700 |
FY | 2022 |
Przychody: | $110.25M |
Zysk brutto: | $87.61M (79.47 %) |
EPS: | $-1.200 |
Financial Reports:
No articles found.
Xeris Pharmaceuticals Inc
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej